Uniqlife Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.70 M
as on 16-11-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.14 Cr
as on 16-11-2024
- Revenue 19.92%
(FY 2023)
- Profit 41.01%
(FY 2023)
- Ebitda 18.51%
(FY 2023)
- Net Worth 22.88%
(FY 2023)
- Total Assets 5.97%
(FY 2023)
About Uniqlife Biosciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.70 M.
The company currently has active open charges totaling ₹4.14 Cr.
Neeraj Sharma and Pinkey Sharma serve as directors at the Company.
- CIN/LLPIN
U51101UP2012PTC050651
- Company No.
050651
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Uniqlife Biosciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Sharma  | Director | 24-May-2012 | Current |
| Pinkey Sharma | Director | 24-May-2012 | Current |
Financial Performance of Uniqlife Biosciences.
Uniqlife Biosciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.92% increase. The company also saw a substantial improvement in profitability, with a 41.01% increase in profit. The company's net worth Soared by an impressive increase of 22.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uniqlife Biosciences?
In 2023, Uniqlife Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 01 Mar 2024 | ₹1.50 M | Open |
Indian Overseas Bank Creation Date: 30 Sep 2023 | ₹1.35 M | Open |
Indian Overseas Bank Creation Date: 18 Oct 2022 | ₹1.00 M | Open |
How Many Employees Work at Uniqlife Biosciences?
Uniqlife Biosciences has a workforce of 26 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uniqlife Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uniqlife Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
